Disulfiram alleviates cardiac hypertrophic injury by inhibiting TAK1-mediated PANoptosis.
- Author:
Wei-Dong LI
1
;
Xuan-Yang SHEN
1
;
Xiao-Lu JIANG
1
;
Hong-Fu WEN
1
;
Yuan SHEN
1
;
Mei-Qi ZHANG
1
;
Wen-Tao TAN
1
Author Information
- Publication Type:Journal Article
- MeSH: Animals; MAP Kinase Kinase Kinases/physiology*; Rats; Myocytes, Cardiac/pathology*; Disulfiram/pharmacology*; Cardiomegaly; Apoptosis/drug effects*; Cell Line; Angiotensin II; Necroptosis/drug effects*; Interleukin-1beta/metabolism*; Receptor-Interacting Protein Serine-Threonine Kinases/metabolism*; Lactones; Resorcinols; Zearalenone/administration & dosage*
- From: Acta Physiologica Sinica 2025;77(2):222-230
- CountryChina
- Language:Chinese
- Abstract: The study aims to examine the effects and potential mechanisms of disulfiram (DSF) on cardiac hypertrophic injury, focusing on the role of transforming growth factor-β-activated kinase 1 (TAK1)-mediated pan-apoptosis (PANoptosis). H9C2 cardiomyocytes were treated with angiotensin II (Ang II, 1 µmol/L) to establish an in vitro model of myocardial hypertrophy. DSF (40 µmol/L) was used to treat cardiomyocyte hypertrophic injury models, either along or in combination with the TAK1 inhibitor, 5z-7-oxozeaenol (5z-7, 0.1 µmol/L). We assessed cell damage using propidium iodide (PI) staining, measured cell viability with CCK8 assay, quantified inflammatory factor levels in cell culture media via ELISA, detected TAK1 and RIPK1 binding rates using immunoprecipitation, and analyzed the protein expression levels of key proteins in the TAK1-mediated PANoptosis pathway using Western blot. In addition, the surface area of cardiomyocytes was measured with Phalloidin staining. The results showed that Ang II significantly reduced the cellular viability of H9C2 cardiomyocytes and the binding rate of TAK1 and RIPK1, significantly increased the surface area of H9C2 cardiomyocytes, PI staining positive rate, levels of inflammatory factors [interleukin-1β (IL-1β), IL-18, and tumor necrosis factor α (TNF-α)] in cell culture media and p-TAK1/TAK1 ratio, and significantly up-regulated key proteins in the PANoptosis pathway [pyroptosis-related proteins NLRP3, Caspase-1 (p20), and GSDMD-N (p30), apoptosis-related proteins Caspase-3 (p17), Caspase-7 (p20), and Caspase-8 (p18), as well as necroptosis-related proteins p-MLKL, RIPK1, and RIPK3]. DSF significantly reversed the above changes induced by Ang II. Both 5z-7 and exogenous IL-1β weakened these cardioprotective effects of DSF. These results suggest that DSF may alleviate cardiac hypertrophic injury by inhibiting TAK1-mediated PANoptosis.
